DERMAPEN 4 Handbuch Seite 23

10 - WARNINGS & CONSIDERATIONS
10.1 - Possible Contraindications
Patients experiencing any of the following active conditions should not proceed with a
Dermapen 4™ clinical treatment without doctors' consent:
• Papulopustular rosacea
• Acne vulgaris stage III-IV
• Herpes simplex
• Warts
• Scleroderma
• Bacterial/fungal infections
• Open lesions
• Solar keratosis
• Skin cancer
• Haemophilia
Topical Local Anaesthetic (TLA) should not be applied on patients experiencing any of
the following active conditions, practices or medications. Treatment however may proceed
without TLA application.
without TLA.
• Pregnancy
• Breastfeeding
• Hepatic disease
• Pseudo cholinesterase defi ciency
• P-aminobenzoic acid (PABA) allergies
• Sulphonamide allergies
• Congenial or idiopathic methaemoglobinaemia
• Arrhythmia medications
10.2 - Possible Side-E ects of Microneedling
• Allergic reaction on patients who su er from cutaneous allergy to metallic products.
• Bacterial infection if the skin is not adequately disinfected before, during and after each
treatment.
• Post-infl ammatory hyperpigmentation in high-risk patients who have been over-treated
while using the Dermapen 4™ on the skin.
• Irregular fi brous tissue deposits in high-risk patients who have not undertaken appropriate
treatment measures.
10.3 - Possible Complications
Possible complications arising from the use of the Dermapen 4™ include:
• Cutaneous eruptions
• Infl ammation, erythema
• Itching and burning sensations
• Cold sore eruption (herpes simplex)
In our experience most
23
Dermapen 4™ treatments are conducted